Cytoprotective effects of nicorandil on hypothermic injury to immature cardiac myocytes--comparison with nitroglycerin, diltiazem and prostaglandin E1.
The purpose of this study was to evaluate the functional and biochemical effects of nicorandil (NRD), nitroglycerin (NTG), diltiazem (DTZ) and prostaglandin E1 (PGE) on cardiac myocytes incubated under hypothermic conditions. Cardiac myocytes were isolated from neonatal rat ventricles and cultured for 4 days with MCDB 107 medium. Myocytes (12.5 x 10(5) myocytes/flask) were then incubated at 4 degrees C for 24 h in media containing various concentrations of NRD, NTG, DTZ or PGE. After hypothermic incubation, creatine kinase (CK) and lactate dehydrogenase (LDH) were measured. The myocytes were cultured for an additional 24 h at 37 degrees C to evaluate the recovery of myocyte beating rate. In the nicorandil groups, 10(-4) M NRD showed a significantly increased beating rate recovery compared to the control (44% vs 25% respectively, as a percentage of the baseline values; i.e., beating rate prior to hypothermic incubation). Although treatment with 10(-6) M diltiazem showed no beneficial effects (10(-6) M; 25%, control; 30%), beating was not observed at all with 10(-4) M or 10(-5) M DTZ. There were no significant changes among the NTG and PGE groups. The release of CK and LDH was significantly suppressed with 10(-4) M NRD (10(-4) M: 24.1 mIU/flask, 257.2; control: 125.4, 459.5, respectively). In contrast, 10(-4) M DTZ showed significantly increased CK and LDH levels compared to its respective control (10(-4) M: 203.3 mIU/flask, 883.4; control: 112.3, 457.4, respectively). There were no significant differences in CK and LDH levels among the NTG and PGE groups.(ABSTRACT TRUNCATED AT 250 WORDS)
Second Department of Surgery, Yamagata University School of Medicine, Japan.
H
H
Orita
M
M
Fukasawa
S
S
Hirooka
H
H
Uchino
K
K
Fukui
M
M
Kohi
M
M
Washio
D000527:Alprostadil / Q000494:pharmacology; D000818:Animals; D002478:Cells, Cultured; D003080:Cold Temperature; D003402:Creatine Kinase / Q000378:metabolism; D015925:Cryopreservation; D003451:Cryoprotective Agents / Q000494:pharmacology*; D004110:Diltiazem / Q000494:pharmacology; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D009206:Myocardium / Q000166:cytology* / Q000201:enzymology; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000494:pharmacology; D020108:Nicorandil; D005996:Nitroglycerin / Q000494:pharmacology; D051381:Rats; D014665:Vasodilator Agents / Q000494:pharmacology*
D003451:Cryoprotective Agents; D014665:Vasodilator Agents; D009536:Niacinamide; D020108:Nicorandil; D007770:L-Lactate Dehydrogenase; D003402:Creatine Kinase; D004110:Diltiazem; D000527:Alprostadil; D005996:Nitroglycerin